Sökning: onr:"swepub:oai:lup.lub.lu.se:7f73adc2-a991-4f8f-a43d-567c60435222" >
Cost of treatment o...
Cost of treatment of schizophrenia in six European countries
-
Salize, Hans Joachim (författare)
-
McCabe, Rosemarie (författare)
-
Bullenkamp, Jens (författare)
-
visa fler...
-
- Hansson, Lars (författare)
- Lund University,Lunds universitet,Institutionen för hälsovetenskaper,Medicinska fakulteten,Department of Health Sciences,Faculty of Medicine
-
Lauber, Christoph (författare)
-
Martinez-Leal, Rafael (författare)
-
Reinhard, Iris (författare)
-
Roessler, Wulf (författare)
-
- Svensson, Bengt (författare)
- Lund University,Lunds universitet,Institutionen för hälsovetenskaper,Medicinska fakulteten,Department of Health Sciences,Faculty of Medicine
-
Torres-Gonzalez, Francisco (författare)
-
van den Brink, Rob (författare)
-
Wiersma, Durk (författare)
-
Priebe, Stefan (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2009
- 2009
- Engelska.
-
Ingår i: Schizophrenia Research. - : Elsevier BV. - 0920-9964. ; 111:1-3, s. 70-77
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://pure.rug.nl/...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background and aims: As part of an RCT in six European sites, the direct mental health care cost for 422 patients with schizophrenia was analysed according to how total and medication costs differed across sites and which variables were likely to predict total or service-specific costs. Method: Service use was recorded continuously during a 12-month follow-up. Prescribed psychotropic medication was recorded at baseline and 12 months later. Service use data were transformed into EURO, log-transformed and analysed using linear regression models. Results: Although samples were homogeneous, large inter-site cost differences were found (annual means ranging from 2958 E in Spain up to 36978 E in Switzerland). Psychopharmacologic costs were much more constant across sites than costs for other services. Total costs were associated more with region or socio-demographic characteristics than with disorder related parameters. Conclusions: The findings confirm remarkable differences in direct costs of patients with schizophrenia across Europe. However, the relative stability of medication costs suggests a need to analyse mechanisms that influence service-specific costs for schizophrenia. (C) 2009 Elsevier B.V. All rights reserved.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Psykiatri (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Psychiatry (hsv//eng)
Nyckelord
- Schizophrenia
- Community care
- Service utilization
- Psychopharmacologic costs
- Cost of care
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Salize, Hans Joa ...
-
McCabe, Rosemari ...
-
Bullenkamp, Jens
-
Hansson, Lars
-
Lauber, Christop ...
-
Martinez-Leal, R ...
-
visa fler...
-
Reinhard, Iris
-
Roessler, Wulf
-
Svensson, Bengt
-
Torres-Gonzalez, ...
-
van den Brink, R ...
-
Wiersma, Durk
-
Priebe, Stefan
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Psykiatri
- Artiklar i publikationen
-
Schizophrenia Re ...
- Av lärosätet
-
Lunds universitet